4.3 Review

Autoimmune Lymphoproliferative Syndrome type III, an indefinite disorder

Journal

LEUKEMIA & LYMPHOMA
Volume 41, Issue 5-6, Pages 501-+

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/10428190109060341

Keywords

ALPS type III; Fas; apoptosis; diagnostic aspects

Ask authors/readers for more resources

Autoimmune Lymphoproliferative Syndrome (ALPS) is a childhood disorder characterized by chronic nonmalignant lymphoproliferation and autoimmunity Although the pathogenesis is not fully understood, deficient Fas mediated apoptosis appears to be an important factor. This deficiency can be caused by a mutation of the APTI gene (ALPS type Ia), of the FasL gene (ALPS type Ib), or of the Caspase-10 gene (ALPS type II), In one sub population of patients, no mutations have been identified as yet (ALPS type III), According to published data, the latter group is much smaller than the group of patients with ALPS type Ia. However, because of the variability of the clinical presentation and the absence of a known genetic defect, this disease is difficult to diagnose, the more so as few data have been reported on these patients. Thus, ALPS type III could be more common than believed until now. In this review we provide evidence for this hypothesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available